AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
203.87
+2.37 (1.18%)
At close: Oct 31, 2024, 4:00 PM
203.10
-0.77 (-0.38%)
After-hours: Oct 31, 2024, 7:08 PM EDT
AbbVie Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for AbbVie stock have an average target of 201.5, with a low estimate of 150 and a high estimate of 231. The average target predicts a decrease of -1.16% from the current stock price of 203.87.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock from 19 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 4 | 4 | 4 | 4 | 7 |
Buy | 8 | 8 | 8 | 8 | 8 | 8 |
Hold | 2 | 1 | 1 | 1 | 1 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 13 | 13 | 13 | 13 | 13 | 19 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
UBS | UBS | Hold Maintains $195 → $200 | Hold | Maintains | $195 → $200 | -1.90% | Oct 31, 2024 |
Morgan Stanley | Morgan Stanley | Buy Maintains $218 → $231 | Buy | Maintains | $218 → $231 | +13.31% | Oct 31, 2024 |
Citigroup | Citigroup | Strong Buy Maintains $170 → $215 | Strong Buy | Maintains | $170 → $215 | +5.46% | Oct 25, 2024 |
B of A Securities | B of A Securities | Hold Maintains $185 → $195 | Hold | Maintains | $185 → $195 | -4.35% | Oct 18, 2024 |
BMO Capital | BMO Capital | Buy Maintains $214 → $220 | Buy | Maintains | $214 → $220 | +7.91% | Oct 17, 2024 |
Financial Forecast
Revenue This Year
56.77B
from 54.32B
Increased by 4.51%
Revenue Next Year
59.79B
from 56.77B
Increased by 5.32%
EPS This Year
11.10
from 2.72
Increased by 308.19%
EPS Next Year
12.33
from 11.10
Increased by 11.05%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 59.4B | 63.0B | 67.9B | ||
Avg | 56.8B | 59.8B | 64.1B | ||
Low | 53.9B | 55.9B | 58.7B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 9.3% | 11.0% | 13.5% | ||
Avg | 4.5% | 5.3% | 7.1% | ||
Low | -0.8% | -1.6% | -1.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 11.77 | 13.31 | 14.92 | ||
Avg | 11.10 | 12.33 | 13.80 | ||
Low | 10.50 | 11.25 | 12.57 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 332.7% | 19.9% | 21.0% | ||
Avg | 308.2% | 11.1% | 11.9% | ||
Low | 285.9% | 1.3% | 2.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.